Ultrasound Trigger Ce‐Based MOF Nanoenzyme For Efficient Thrombolytic Therapy
Advanced Science · 2024-05 · 11 (20)
DOI: 10.1002/advs.202304441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.04.2024. Verfasst von Jianggui Shan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Reiji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Cerium, Metal-Organic Frameworks, Thrombolytic Therapy, Reactive Oxygen Species. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Shanghai Municipal Health Commission, Medical Transformation Crossing Funding from Shanghai Jiao Tong University.
Abstract (Originalsprache)
The inflammatory damage caused by thrombus formation and dissolution can increase the risk of thrombotic complications on top of cell death and organ dysfunction caused by thrombus itself. Therefore, a rapid and precise thrombolytic therapy strategy is in urgent need to effectively dissolve thrombus and resist oxidation simultaneously. In this study, Ce‐UiO‐66, a cerium‐based metal–organic framework (Ce‐MOF) with reactive oxygen species (ROS) scavenging properties, encapsulated by low‐immunogenic mesenchymal stem cell membrane with inflammation‐targeting properties, is used to construct a targeted nanomedicine Ce‐UiO‐CM. Ce‐UiO‐CM is applied in combination with external ultrasound stimulation for thrombolytic therapy in rat femoral artery. Ce‐UiO‐66 has abundant Ce (III)/Ce (IV) coupling sites that react with hydrogen peroxide (H 2 O 2 ) to produce oxygen, exhibiting catalase (CAT) activity. The multi‐cavity structure of Ce‐UiO‐66 can generate electron holes, and its pore channels can act as micro‐reactors to further enhance its ROS scavenging capacity. Additionally, the porous structure of Ce‐UiO‐66 and the oxygen produced by its reaction with H 2 O 2 may enhance the cavitation effects of ultrasound, thereby improving thrombolysis efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Reiji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
ORCID-Profile: Peifeng Liu
Förderung
- National Natural Science Foundation of China
- Foundation of Shanghai Municipal Health Commission
- Medical Transformation Crossing Funding from Shanghai Jiao Tong University
- Master's and Doctoral Innovation Foundation of Shanghai Cancer Institute
Zitieren
APA
Shan, J., Du, L., Wang, X., Zhang, S., Li, Y., Xue, S., Tang, Q., & Liu, P. (2024). Ultrasound Trigger Ce‐Based MOF Nanoenzyme For Efficient Thrombolytic Therapy. Advanced Science, 11(20). https://doi.org/10.1002/advs.202304441
Vancouver
Shan J, Du L, Wang X, Zhang S, Li Y, Xue S, et al. Ultrasound Trigger Ce‐Based MOF Nanoenzyme For Efficient Thrombolytic Therapy. Advanced Science. 2024;11(20). doi:10.1002/advs.202304441
BibTeX
@article{Shan2024,
author = {Shan, Jianggui and Du, Ling and Wang, Xingang and Zhang, Sidi and Li, Yiping and Xue, Song and Tang, Qianyun and Liu, Peifeng},
title = {Ultrasound Trigger Ce‐Based MOF Nanoenzyme For Efficient Thrombolytic Therapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {20},
doi = {10.1002/advs.202304441}
}
EUVIMED